| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 603259.CN | WuXi AppTec Co., Ltd. Class A | 73.8 | ¤38,820 | CN |
| 002001.CN | Zhejiang NHU Co. Ltd. Class A | 68.8 | ¤15,238 | CN |
| 000963.CN | Huadong Medicine Co., Ltd. Class A | 60.8 | ¤9,077 | CN |
| 688336.CN | Sunshine Guojian Pharmaceutical (Shangha | 63.2 | ¤6,095 | CN |
| 688578.CN | Shanghai Allist Pharmaceuticals Co. Ltd. | 87.3 | ¤6,005 | CN |
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 300515.CN | Hunan Sundy Science and Technology Co., | 65.0 | ¤546 | CN |
| 603309.CN | WELL LEAD MEDICAL CO LTD Class A | 65.0 | ¤647 | CN |
| 688410.CN | SWS Hemodialysis Care Co., Ltd. Class A | 56.2 | ¤712 | CN |
| 300871.CN | Hvsen Biotechnology Co. Ltd. Class A | 65.8 | ¤728 | CN |
| 688758.CN | Suzhou Sepax Technologies Co., Ltd. Clas | 63.9 | ¤1,098 | CN |
| Symbol | Name | Grade | Times* | Country |
|---|---|---|---|---|
| 002001.CN | Zhejiang NHU Co. Ltd. Class A | 68.8 | 20 | CN |
| 000423.CN | Dong-E-E-Jiao Co., Ltd. Class A | 75.3 | 19 | CN |
| 000915.CN | Shandong Wit Dyne Health Co., Ltd. Class | 75.0 | 11 | CN |
| 300357.CN | Zhejiang Wolwo Bio-Pharmaceutical Co., L | 62.4 | 11 | CN |
| 000963.CN | Huadong Medicine Co., Ltd. Class A | 60.8 | 10 | CN |
| 600750.CN | China Resources Jiangzhong Pharmaceutica | 58.3 | 10 | CN |
| 600211.CN | Tibet Rhodiola Pharmaceutical Holding Co | 71.2 | 9 | CN |
| 600285.CN | Henan Lingrui Pharmaceutial Co., Ltd. Cl | 74.5 | 9 | CN |
| 688278.CN | Xiamen Amoytop Biotech Co., Ltd. Class A | 84.2 | 7 | CN |
| 002773.CN | Chengdu Kanghong Pharmaceutical Group Co | 62.4 | 6 | CN |
| Average Market Cap | ¤4,265 |
| Median Market Cap | ¤1,952 |
| Avg. 3 Mo. Dollar Vol. | ¤45,356,190 |
| Avg. 3 Mo. Trading Vol. | 7,213,195 |
| Last Rebalance Date | 12/22/2025 |
| Companies Replaced | 15 |
| Biggest Sector Increase | Health Care |
| Biggest Sector Decrease | Health Care |
| Trailing P/E Ratio (12 Mo.) | 20.4 |
| Forward P/E Ratio (12 Mo.) | 14.8 |
| Price/Book Ratio | 3.6 |
| Avg. Revenue Chg. - 3 Yr | 45.4% |
| Avg. Op. Income Chg. - 3 Yr. | 120.5% |
| Avg. EPS Growth - 3 Yr. | 27.4% |
| Avg. EPS Growth - 1 Yr. | 16.4% |
| Avg. Operating Margin | 24.2% |
| Avg. LT Debt to Total Capital | 6.6% |
| Avg. Return on Equity | 16.7% |
| Dividend Yield | 1.6% |
| China Health Care Index | 65.04 |
| China | 100.0% |
